84 related articles for article (PubMed ID: 8426469)
1. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Garand R; Voisin S; Papin S; Praloran V; Lenormand B; Favre M; Philip P; Bernier M; Vanhaecke D; Falkenrodt A
Leukemia; 1993 Feb; 7(2):161-7. PubMed ID: 8426469
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Garand R; Vannier JP; Béné MC; Faure G; Favre M; Bernard A
Leukemia; 1990 Nov; 4(11):739-44. PubMed ID: 2232884
[TBL] [Abstract][Full Text] [Related]
3. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
4. Rearrangement of T cell receptor beta, gamma, and delta gene loci in human pre-T cell acute lymphoblastic leukemia.
Raghavachar A; Thiel E; Hansen-Hagge TE; Kranz B; Bartram CR
Leukemia; 1989 Jun; 3(6):413-8. PubMed ID: 2542699
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
6. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
[TBL] [Abstract][Full Text] [Related]
7. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.
Kimura N; Akiyoshi T; Uchida T; Okamura J; Kozuru M; Nishimura J; Ohyashiki JH; Kikuchi M; Niho Y; Okumura M
Leukemia; 1996 Apr; 10(4):650-7. PubMed ID: 8618442
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
11. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
14. Gene rearrangements in T-cell lymphoblastic lymphoma.
Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
16. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
17. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukaemia/lymphoma cases.
Maha A; Gan GG; Koh CL
Hematology; 2010 Dec; 15(6):382-90. PubMed ID: 21114900
[TBL] [Abstract][Full Text] [Related]
19. Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.
Kimura N; Takihara Y; Akiyoshi T; Yoshida T; Ohshima K; Kawara T; Hisano S; Kozuru M; Okumura M; Kikuchi M
Cancer Res; 1989 Aug; 49(16):4488-92. PubMed ID: 2501027
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.
Nuss R; Kitchingman G; Cross A; Zipf TF; Antoun GR; Bernstein I; Behm F; Pullen DJ; Crist W; Mirro J
Leukemia; 1988 Nov; 2(11):722-7. PubMed ID: 2972889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
